Lumida
/TRVI
⌘K
Trevi Therapeutics Inc

Trevi Therapeutics Inc

TRVI
$19.07USD+9.85%+1.71 today

MARKET CAP

2.7B

P/E (TTM)

FWD P/E

DAY RANGE

$17 – $20

52W RANGE

$7
$20

AI Summary

Stalk
Buy NowHigh

In a Stage 2 advancing trend with clear higher highs and higher lows, TRVI is undergoing a shallow pullback into the rising 9 and 20 EMAs, which have held as support. Despite overbought readings, volume and momentum behavior remain healthy, aligning with a speculative continuation approach. Medium-term bias is bullish, and current price behavior offers a tactical Buy Now opportunity on this pullback into the EMA support zone.

  • Pro forma cash of $334M extends runway to 2030 after $162M raise.
  • Phase II trials met primary endpoint, showing statistically significant cough reduction.
  • Q1 net loss $0.09/share underscores ongoing unprofitability.
Full analysis →
Insider Trades17 trades
DateSideTickerInsiderRoleSharesPriceMkt Cap52W High52W LowValue% ChgRuleAI View
Dec 2, 2025BuyTRVIChristopher Galletta4,225$0.51$2.7B-5.69%+191.15%$2.2K+11.22%Buy Now
Mar 25, 2025SellTRVIThomas SciasciaChief Scientific Officer5,262$4.01$2.7B-5.69%+191.15%$21.1K+0.00%Buy Now
Mar 21, 2025SellTRVIJennifer L GoodPresident & CEO10,526$4.00$2.7B-5.69%+191.15%$42.2K+0.00%Buy Now
Mar 10, 2025BuyTRVIFarrell SimonChief Commercial Officer193,876$4.49$2.7B-5.69%+191.15%$870.5K+5.75%10b5-1Buy Now
Jan 7, 2025BuyTRVILisa DelfiniChief Financial Officer6,000$0.51$2.7B-5.69%+191.15%$3.1K+2.89%Buy Now
Dec 13, 2024BuyTRVIChristopher Galletta15,000$0.51$2.7B-5.69%+191.15%$7.7K+60.16%Buy Now
Sep 6, 2024SellTRVIJennifer L GoodPresident & CEO12,118$2.23$2.7B-5.69%+191.15%$27.0K+0.00%Buy Now
Sep 3, 2024SellTRVIJennifer L GoodPresident & CEO110,242$2.26$2.7B-5.69%+191.15%$249.0K+0.00%Buy Now
Aug 19, 2024SellTRVIThomas SciasciaChief Scientific Officer32,992$2.20$2.7B-5.69%+191.15%$72.5K+0.00%Buy Now
Aug 14, 2024SellTRVIThomas SciasciaChief Scientific Officer63,010$2.10$2.7B-5.69%+191.15%$132.3K+0.00%Buy Now
May 29, 2024BuyTRVIThomas SciasciaChief Scientific Officer112,722$2.36$2.7B-5.69%+191.15%$266.1K+1.26%Buy Now
May 22, 2024BuyTRVILisa DelfiniChief Financial Officer20,393$0.97$2.7B-5.69%+191.15%$19.7K+7.94%Buy Now
May 20, 2024SellTRVIJennifer L GoodPresident & CEO50,074$2.52$2.7B-5.69%+191.15%$126.4K+0.00%Buy Now
May 10, 2024SellTRVIJennifer L GoodPresident & CEO9,156$2.54$2.7B-5.69%+191.15%$23.3K+0.00%Buy Now
Oct 11, 2023BuyTRVILisa DelfiniChief Financial Officer3,077$0.90$2.7B-5.69%+191.15%$2.8K+1.11%10b5-1Buy Now
Sep 11, 2023BuyTRVILisa DelfiniChief Financial Officer3,002$0.91$2.7B-5.69%+191.15%$2.7K+1.18%10b5-1Buy Now
Aug 11, 2023BuyTRVILisa DelfiniChief Financial Officer2,974$0.94$2.7B-5.69%+191.15%$2.8K+1.21%10b5-1Buy Now